뉴스
GenixCure unveils AI-powered next-generation AAV capsid...
2026-05-22
- Genixcure unveils next-generation AAV capsid research results based on AI and primate validation at ASGCT 2026
- Multiple 2nd-generation GenC2·GenC2M variants secured with up to 30-fold improved transduction efficiency over parental capsids
- Proprietary in vitro receptor-mediated screening system established with cross-species validation in human and non-human primate models
- Platform value demonstrated with 180-fold improvement in BBB penetration and 64-fold increase in transferrin shuttle activity
